When a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million to bankroll an audacious mission: to add 10 years to ...
As a postdoctoral researcher at Stanford University, Kristen Fortney used bioinformatics to study the genetics of supercentenarians — people who live to the age of 110 and beyond. Now ...
“Why is it in popular culture, if you want to live forever, you are evil and you want to kill babies on the side?” says Martin Borch Jensen.
It’s fast ...
Tech billionaires are funding research to help us live longer and healthier lives, but experts warn of an ethical minefield ahead.
When Nir Barzilai specialised in anti-ageing science 30 years ...
Scientists are great at making mice live longer.
Rapamycin, widely prescribed to prevent organ rejection after a transplant, increases the life expectancy of middle-age mice by as much as 60 ...
The parents of a 2-year-old girl write that their daughter “could die within the next year” because a genetic mutation is causing her heart to fail.
“Time is quickly running ...
A guide to contemporary doomsday scenarios — from the threats you know about to the ones you never think of.
And here we are at the crux of our existential ...
The 2020 Nobel Laureate shares her thoughts on the first decade of CRISPR genome editing, where the technology is heading next, and what it needs to get there.
Last month, Genetic ...
Research labs are pursuing technology to “reprogram” aging bodies back to youth.
A little over 15 years ago, scientists at Kyoto University in Japan made a remarkable discovery. When they ...
Sanofi has teamed up with Scribe Therapeutics to write the next chapter in its natural killer (NK) cell therapy story, paying $25 million upfront and committing to $1 billion ...
Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, today announced a strategic collaboration with Sanofi for the use of Scribe’s CRISPR ...
It’s entirely possible, maybe even likely, that during some slow day at the lab early in her career, Jennifer Doudna, in a moment of private ambition, daydreamed about making ...
“CRISPR-by-design” is the idea behind Scribe Therapeutics, a company spun out from Jennifer Doudna’s Nobel-winning lab that’s competing in a closely-tracked field of genome editor companies just starting to ...
Cartography Biosciences, a precision medicine company creating therapeutics guided by the first-ever comprehensive antigen atlas for immuno-oncology targets, launched today with $57 million in initial funding. 8VC led the ...
Jennifer Doudna was staring at a computer screen filled with a string of As, Cs, Ts, and Gs—the letters that make up human DNA—and witnessing a debilitating genetic disease ...
On June 28, 2012, a joint press release went out from the U.S. Department of Energy and the Lawrence Berkeley National Laboratory announcing a new paper in Science from an ...
The gene-editing tool has transformed the study of human disease, but before it can revolutionize treatments, researchers will need to solve three basic problems.
Ten years ago this week, a report of ...
The gene-editing technology has led to innovations in medicine, evolution and agriculture — and raised profound ethical questions about altering human DNA.
Ten years ago this week, Jennifer Doudna and ...
New funding from the Chan Zuckerberg Initiative kickstarts CRISPR-enabled carbon removal research at the Innovative Genomics Institute
A new research program at the Innovative Genomics Institute (IGI), supported by a ...
LatchBio, a company accelerating the pace of scientific progress by enabling researchers to store and analyze data without touching code or cloud infrastructure, today announced a $28 million Series ...
Innovative Genomics Institute Founder, Nobel Laureate, and CRISPR co-discoverer Jennifer Doudna joins Emily Chang to discuss the future of the CRISPR technology and its commercialization, as well as the ...
Sixth Street Chief Science Adviser and Nobel laureate Jennifer Doudna, co-founder of the CRISPR genome editing technology, and Sixth Street Vice Chairman and Partner R. Martin Chavez join Emily ...
Every second of every day inside your body, proteins are made, moved, modified, and destroyed over and over again. These proteins can be short strings of amino acids or ...
Benjamin Oakes is carving out a space in the gene-editing field by developing what he calls a "genetic scalpel."
After researching gene editing in the labs of CRISPR pioneer Jennifer ...
CRISPR is the latest and most powerful technique for changing the genetic code of living things. This method of gene editing is already showing great promise in treating people ...
Gene editing has become one of biotech's hottest areas as the first-in-human results have suggested the technology holds the potential to cure certain diseases with a single treatment.
In 2021, ...
Last year, Jennifer Doudna and Emmanuelle Charpentier became the first all-woman team to win the Nobel Prize in Chemistry for their work developing CRISPR-Cas9, the gene-editing technology. The technology ...
Proteins are the building blocks of the human body and have many critical roles. Since proteins are involved in multiple biological functions, they also play an important role in ...
Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the completion of its business combination with Arya Sciences Acquisition Corp III ...
Digital data related to Nobel Prize-winning inventions for gene editing and cancer immunotherapy will be sold connected to non-fungible tokens next week, a novel way for the University of ...
Developing therapeutics is difficult—developing neurotherapeutics is even harder. The blood-brain barrier protecting the brain from unwanted substances makes it extremely difficult for neurotherapeutics to reach their target.
Herophilus, a San ...
How much will someone be willing to pay for a few pages of quarter-century-old bureaucratic university paperwork that have been turned into a blockchain-encoded piece of digital art?
Berkeley announced ...
Herophilus, a leading biotechnology company developing neurotherapeutics to cure complex brain diseases, has appointed Sharath Hegde, Ph.D. as the company’s new Chief Scientific Officer. Dr. Hegde brings over 30 ...
Ben Oakes’ dive inside the human mind colors his leadership role at gene editing startup Scribe Therapeutics.
As an undergrad, Ben Oakes wanted to learn how the mind worked — ...
Scribe Therapeutics is adding another $100 million to its coffers six months after unveiling a $20 million series A and a partnership with Biogen to work on gene editing ...
Scribe Therapeutics has completed an oversubscribed $100-million Series B financing, with aims to further develop its suite of custom gene-editing and delivery technologies based on molecular engineering, as well ...
Nearly a decade ago, when the first CRISPR companies started looking for capital, Behzad Aghazadeh passed.
Aghazadeh, one of biotech’s more opinionated investors, had invested in gene editing before, but ...
Imagine being able to change the genes responsible for causing diseases. For Scribe Therapeutics, a gene-editing company that develops genetic medicines, this is no longer a dream but a ...
When last year’s Nobel prize for chemistry was awarded to biochemist Jennifer Doudna and microbiologist Emmanuelle Charpentier for their work in developing the technique of gene editing known as Crispr-Cas9 ...
In the spring of 2014, Jennifer Doudna had a nightmare.
The Berkeley biochemist had helped to invent a powerful new technology that made it possible to edit the human genome—an ...
In The Code Breaker, Walter Isaacson recounts the drama of the discovery in a digestible narrative that tackles the promise and the peril of Crispr.
For Isaacson, an accomplished storyteller of ...
In February, Jennifer Doudna, one of America’s most prominent scientists, was still focused on CRISPR—the gene-editing tool that she’d co-discovered and that won her a Nobel Prize in October. But ...
When Jennifer Doudna woke up, she realised her phone had been buzzing on and off for some time. It was still dark outside. In fact, her phone told her ...
Increasingly inexpensive genetic sequencing and engineering tools could upend everything from health care to fuel.
Why it matters: This bio revolution could lead to a world that is more sustainable and ...
Clinical trials of genome-editing agents — including CRISPR–Cas9 editors, zinc finger nucleases and TALENs — are pushing ex vivo, immuno-oncology and in vivo treatment frontiers.
Focus
CRISPR
Client
UC Berkeley
READ THE ...
Ever since the discovery of the structure of DNA in the 1950s, scientists have been dreaming about rewriting the code of life. What if we could correct genetic mutations that ...
As investors await results from the first U.S. clinical trials of the gene-editing system known as Crispr, scientists are focused on finding ways to administer it directly into humans, ...
The first decade of the 21st century introduced us to sweeping mobile and social revolutions largely driven by names like Jobs, Zuckerberg and Bezos. In the second decade that's now ...
The first “test-tube baby” is now more than 40 years old, and all is well with her. Millions more babies have followed by means of in vitro fertilization, or ...
China has used the genome editor more aggressively, on more species, than any other country.
Early one February morning, researchers harvest six eggs from a female rhesus macaque—one of 4000 ...
As far as experts are concerned, the technology of gene editing is nowhere near ready to be used to create gene-edited babies. This, of course, is separate from the ...
The drug maker GlaxoSmithKline announced Thursday that it would team up with some of the nation’s most prominent CRISPR researchers to use the gene-editing technology in a search for ...
Top CRISPR researchers at two University of California (UC) campuses have teamed up with pharmaceutical giant GlaxoSmithKline (GSK) to form a new laboratory in San Francisco that will exploit the ...
When Rachel Haurwitz started her biology Ph.D. at the University of California, Berkeley, the award-winning biochemist Jennifer Doudna suggested Haurwitz investigate part of a bacterial immune system. She studied how ...
Written by Dr. Jennifer Doudna, Professor of Chemistry and Molecular and Cell Biology, UC Berkeley
The UN’s Sustainable Development Goals (SDGs) are an important call to action.
The data, consensus of ...
Two sisters entered the world prematurely one October night last year by emergency caesarean section. Staff at the Chinese hospital swaddled them in white, laying them in incubators.
The twins ...
Powerful gene-editing tools have the potential to heal—or to harm. Now there’s a race to develop the antidote to the next bioweapon.
In September 2016, Jennifer Doudna called a new ...
While ethicists debate the applications of blockbuster gene-editing tool Crispr in human healthcare, an inventor of the tool believes it has a more immediate application: improving our food.
"I think ...